Literature DB >> 28979656

Treatment of Actinic Purpura.

Roger I Ceilley1.   

Abstract

Mature skin is prone to bruising, resulting in a condition known as actinic purpura, characterized by unsightly ecchymosis and purple patches. Similar to other skin conditions, the incidence of actinic purpura increases with advancing age and occurs with equal frequency among men and women. The unsightly appearance of actinic purpura may be a source of emotional distress among the elderly. A new product has been formulated specifically for the treatment of actinic purpura. This product contains retinol, α-hydroxy acids, arnica oil, ceramides, niacinamide, and phytonadione, which effectively treat actinic purpura by improving local circulation, thickening the skin, and repairing the skin barrier. The objective of this paper is to review the beneficial properties of these ingredients and their respective roles in the treatment of actinic purpura.

Entities:  

Year:  2017        PMID: 28979656      PMCID: PMC5605207     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  48 in total

Review 1.  Skin aging: postulated mechanisms and consequent changes in structure and function.

Authors:  M Yaar; B A Gilchrest
Journal:  Clin Geriatr Med       Date:  2001-11       Impact factor: 3.076

2.  Two randomized, controlled, comparative studies of the stratum corneum integrity benefits of two cosmetic niacinamide/glycerin body moisturizers vs. conventional body moisturizers.

Authors:  Jeremy C Christman; Deborah K Fix; Sawanna C Lucus; Debrah Watson; Emma Desmier; Rolanda J Johnson Wilkerson; Charles Fixler
Journal:  J Drugs Dermatol       Date:  2012-01       Impact factor: 2.114

Review 3.  Nicotinamide and the skin.

Authors:  Andrew C Chen; Diona L Damian
Journal:  Australas J Dermatol       Date:  2014-03-17       Impact factor: 2.875

4.  A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.

Authors:  Andrew C Chen; Andrew J Martin; Bonita Choy; Pablo Fernández-Peñas; Robyn A Dalziell; Catriona A McKenzie; Richard A Scolyer; Haryana M Dhillon; Janette L Vardy; Anne Kricker; Gayathri St George; Niranthari Chinniah; Gary M Halliday; Diona L Damian
Journal:  N Engl J Med       Date:  2015-10-22       Impact factor: 91.245

5.  Niacinamide: A B vitamin that improves aging facial skin appearance.

Authors:  Donald L Bissett; John E Oblong; Cynthia A Berge
Journal:  Dermatol Surg       Date:  2005-07       Impact factor: 3.398

Review 6.  alpha-Hydroxy acid-based cosmetic procedures. Guidelines for patient management.

Authors:  R C Tung; W F Bergfeld; A T Vidimos; B K Remzi
Journal:  Am J Clin Dermatol       Date:  2000 Mar-Apr       Impact factor: 7.403

7.  A survey of skin problems and skin care regimens in the elderly.

Authors:  S Beauregard; B A Gilchrest
Journal:  Arch Dermatol       Date:  1987-12

8.  Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin.

Authors:  D L Bissett; K Miyamoto; P Sun; J Li; C A Berge
Journal:  Int J Cosmet Sci       Date:  2004-10       Impact factor: 2.970

Review 9.  Skin diseases associated with the depletion of stratum corneum lipids and stratum corneum lipid substitution therapy.

Authors:  Fitsum F Sahle; Tsige Gebre-Mariam; Bodo Dobner; Johannes Wohlrab; Reinhard H H Neubert
Journal:  Skin Pharmacol Physiol       Date:  2014-08-29       Impact factor: 3.479

10.  Effect of a lipid-rich emollient containing ceramide 3 in experimentally induced skin barrier dysfunction.

Authors:  M Kucharekova; J Schalkwijk; P C M Van De Kerkhof; P G M Van De Valk
Journal:  Contact Dermatitis       Date:  2002-06       Impact factor: 6.600

View more
  2 in total

Review 1.  Benefits and adverse events of melatonin use in the elderly (Review).

Authors:  Lucreția Anghel; Liliana Baroiu; Corina Rișcă Popazu; Diana Pătraș; Silvia Fotea; Alexandru Nechifor; Anamaria Ciubara; Luiza Nechita; Carmina Liana Mușat; Ioana Anca Stefanopol; Alin Laurențiu Tatu; Alexandru Bogdan Ciubara
Journal:  Exp Ther Med       Date:  2022-01-14       Impact factor: 2.447

2.  EGb 761® Does Not Affect Blood Coagulation and Bleeding Time in Patients with Probable Alzheimer's Dementia-Secondary Analysis of a Randomized, Double-Blind Placebo-Controlled Trial.

Authors:  Charlotte Kloft; Robert Hoerr
Journal:  Healthcare (Basel)       Date:  2021-12-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.